Hui Zhang | Clinical Neuroscience | Best Researcher Award

Prof. Hui Zhang | Clinical Neuroscience | Best Researcher Award

Prof. Hui Zhang | Northwestern University | United States

Hui Zhang is a Professor in the Division of Biostatistics, Department of Preventive Medicine at Northwestern University Feinberg School of Medicine, where he also holds appointments at the Robert H. Lurie Comprehensive Cancer Center, the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, and the Center for Epidemiology and Population Health. he serves as Director of the Northwestern Brain Tumor SPORE Biostatistics and Bioinformatics Core and leads the Biostatistics and Data Management Core at the Mesulam Center. With a Ph.D. in Statistics from the University of Rochester, her academic foundation spans pharmacology, neurophysiology, and biology, reflecting her interdisciplinary expertise in biostatistics and biomedical research. His previous experience includes research roles at St. Jude Children’s Research Hospital, where she contributed significantly to clinical and statistical protocol development. Professor Zhang’s work focuses on statistical methodologies for cancer and neurological disease research, data integration, and bioinformatics applications. he is an active member of several professional societies, including the American Statistical Association and the International Chinese Statistical Association. A highly cited researcher, she has accumulated over 11,422 citations, an h-index of 43, and an i10-index of 100, demonstrating her substantial impact and leadership in the fields of biostatistics and medical data science.

Profile: Google Scholar

Featured Publications

Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., et al. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. New England Journal of Medicine, 361(14), 1329–1338.

Gunzler, D., Chen, T., Wu, P., & Zhang, H. (2013). Introduction to mediation analysis with structural equation modeling. Shanghai Archives of Psychiatry, 25(6), 390–394.

Wan, T., Jun, H. U., Pan, W. U., & Hua, H. E. (2015). Kappa coefficient: A popular measure of rater agreement. Shanghai Archives of Psychiatry, 27(1), 62–67.

Pu, J., Wang, S., Yin, Y., Zhang, G., Carter, R. A., Wang, J., Xu, G., Sun, H., Wang, M., et al. (2015). Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proceedings of the National Academy of Sciences, 112(2), 548–553.

Guy, C. S., Vignali, K. M., Temirov, J., Bettini, M. L., Overacre, A. E., Smeltzer, M., et al. (2013). Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nature Immunology, 14(3), 262–270.

Shen, S., Chen, X., Cai, J., Yu, J., Gao, J., Hu, S., Zhai, X., Liang, C., Ju, X., Jiang, H., et al. (2020). Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome–positive acute lymphoblastic leukemia: A randomized clinical trial. JAMA Oncology, 6(3), 358–366.

Sonabend, A. M., Gould, A., Amidei, C., Ward, R., Schmidt, K. A., Zhang, D. Y., et al. (2023). Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: A phase 1 trial. The Lancet Oncology, 24(5), 509–522.

Efstratios Stylianos Pyrgelis | Neurochemistry | Best Researcher Award

Dr. Efstratios Stylianos Pyrgelis | Neurochemistry | Best Researcher Award

Dr. Efstratios Stylianos Pyrgelis | National and Kapodistrian University of Athens | Greece

Dr. Efstratios-Stylianos Pyrgelis is a distinguished Neurologist and Ph.D. scholar affiliated with the National and Kapodistrian University of Athens. His extensive research contributions span neurochemistry, neuroimaging, and normal pressure hydrocephalus, reflecting a deep commitment to advancing clinical neuroscience. With over 40 published articles in SCI- and Scopus-indexed journals and authorship of 4 international medical books, Dr. Pyrgelis has established a strong academic footprint. His scholarly influence is demonstrated by a total of 510 citations, an h-index of 11, and an i10-index of 12, as recorded on Google Scholar. As a Review Editor for Frontiers in Neurology and Guest Editor for Diagnostics, he plays a pivotal role in shaping contemporary neurological research. He collaborates with the CNS Alliance Research Group and maintains professional memberships with the Greek Neurologic Society and the Medical Association of Chios. Beyond academia, he has contributed to consultancy projects linking research with clinical applications. Through his innovative work and international collaborations, Dr. Pyrgelis continues to contribute significantly to the understanding and treatment of neurological disorders, reinforcing his reputation as one of Greece’s leading researchers in the field of neuroscience.

Profiles: Orcid | Research Gate

Featured Publications

Pyrgelis, E.-S., Paraskevas, G. P., Constantinides, V. C., Boufidou, F., Stefanis, L., & Kapaki, E. (2024). In vivo prevalence of beta-amyloid pathology and Alzheimer’s disease co-pathology in idiopathic normal-pressure hydrocephalus—Association with neuropsychological features. Biomedicines, 12(8), 1898.

Pyrgelis, E.-S., Paraskevas, G. P., Constantinides, V. C., Boufidou, F., Papaioannou, M., Stefanis, L., & Kapaki, E. (2023). Alzheimer’s disease CSF biomarkers as possible indicators of tap-test response in idiopathic normal pressure hydrocephalus. Brain Sciences, 13(11), 1593.

Angelopoulou, E., Pyrgelis, E.-S., Ahire, C., Suman, P., Mishra, A., & Piperi, C. (2023). Functional implications of protein arginine methyltransferases (PRMTs) in neurodegenerative diseases. Biology, 12(9), 1257.

Pyrgelis, E.-S., Velonakis, G., Papageorgiou, S. G., Stefanis, L., Kapaki, E., & Constantinides, V. C. (2023). Imaging markers for normal pressure hydrocephalus: An overview. Biomedicines, 11(5), 1265.

Constantinides, V. C., Paraskevas, G. P., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Stefanis, L., & Kapaki, E. (2023). CSF Aβ42 and Aβ42/Aβ40 ratio in Alzheimer’s disease and frontotemporal dementias. Diagnostics, 13(4), 783.

Constantinides, V. C., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Ghika, A., Koros, C., Liakakis, G., Papageorgiou, S., Stefanis, L., Paraskevas, G. P., et al. (2023). Application of the AT(N) and other CSF classification systems in behavioral variant frontotemporal dementia. Diagnostics, 13(3), 332.

Angelopoulou, E., Pyrgelis, E.-S., & Piperi, C. (2022). Emerging potential of the phosphodiesterase (PDE) inhibitor ibudilast for neurodegenerative diseases: An update on preclinical and clinical evidence. Molecules, 27(23), 8448.